NDC codes

FDA NDC Directory
Product NDC (as listed)0781-1089Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00781-1089Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0781-1089-0100781108901100 TABLET in 1 BOTTLE (0781-1089-01)Marketed from Mar 25, 1998
0781-1089-0500781108905500 TABLET in 1 BOTTLE (0781-1089-05)Marketed from Mar 25, 1998

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Alprazolam
Generic name (nonproprietary)
alprazolam
Active ingredients
Alprazolam — 2 mg/1
Dosage form
Tablet
Route
Oral
Labeler
Sandoz Inc
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 074909
Marketing start
Marketing end
DEA schedule
CIV
Other FDA classes
Benzodiazepines (Chemical structure)
Identifiers
Product ID 0781-1089_4c8c7366-aa3b-4124-9d64-67fb0ead6e15SPL ID 4c8c7366-aa3b-4124-9d64-67fb0ead6e15SPL set ID d9b0e228-17cf-40d7-b62e-5050311c571cRxCUI 197321, 197322, 308047, 308048UNII YU55MQ3IZY
Pharmacologic class
Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400781108901 followed by a unit qualifier and the quantity

Package 00781-1089-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Alprazolam tablets are indicated for the: • acute treatment of generalized anxiety disorder (GAD) in adults. • treatment of panic disorder (PD), with or without agoraphobia in adults. Alprazolam tablets are a benzodiazepine indicated for the: • Acute treatment of generalized anxiety disorder in adults. ( 1 ) • Treatment of panic disorder with or without agoraphobia in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074909

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074909
ProductStrengthForm · routeLabelerProduct NDC
AlprazolamAlprazolam 2 mg/1TabletOralBryant Ranch Prepack71335-0920
AlprazolamAlprazolam 2 mg/1TabletOralProficient Rx LP63187-444
AlprazolamAlprazolam 2 mg/1TabletOralPD-Rx Pharmaceuticals, Inc.55289-523
AlprazolamAlprazolam 2 mg/1TabletOralA-S Medication Solutions50090-2819

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in